Agoracom: Small Cap Investment - Zenith Epigenetics - Re: BIO-Europe Presentation is up

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

BIO-Europe Presentation is up

BearDownAZ

Nov 07, 2017 12:02PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO-Europe Presentation is up

in response to

BIO-Europe Presentation is up

BearDownAZ

posted on Nov 07, 2017 12:23PM

Another observation. Slide 17 from the October 17, 2017 presentation had data updated through September 20, 2017. Today's slide 17 only indicated "Updated October, 2017." However, patient data is only shifted 3 weeks between the two presentations. Therefore, we can estimate that the patient data disclosed today is approximately through October 11th, 2017......about 4 weeks behind current status.